Smoking Associated With Damage to the Lipid Layer of the Ocular Surface
Accepted 23 December 2005. published online 03 February 2006.
Purpose
To evaluate the effects of smoking on ocular surface.
Design
Prospective, comparative, interventional case series.
Methods
setting: Institutional. study population: Sixty smokers (33 men, 27 women) and 34 healthy subjects (18 men, 16 women) were enrolled into this study. Patients with associated ophthalmic or systemic diseases, and history of contact lens use and ocular surgery were excluded. The duration of average smoking was 13.1 years (range 5 to 35 years). intervention:Ocular surface was evaluated by measuring corneal and conjunctival sensitivity, surface staining with fluorescein, tear film breakup time, Schirmer 1 test, and conjunctival impression cytology. Dry eye symptoms were scored by questionnaire. Kinetic analysis of sequential tear interference images obtained by a DR-1 tear lipid layer interferometry was used to investigate the precorneal lipid layer spread. Results were compared with a control group. main outcome measures: Comparison of subjective complaints with objective parameters in cigarette smokers and normal subjects.
Results
In the smoker group, the mean Schirmer 1 test value was 10.8 mm (range 8 to 14 mm). The mean breakup time was 5.3 seconds (range 1 to 10 seconds), the average conjunctival sensitivity was 26.2 mm (range 0 to 45 mm), and the average central corneal sensitivity was 37.6 mm (range 5 to 60 mm). There was no statistically significant difference in goblet cell densities or in Schirmer 1 test values between smokers and controls (P > .05). Higher grades of lipid layer changes were observed in smokers by DR-1 interferometry kinetic analysis.
Conclusions
Smoking has deteriorating effects on the lipid layer of precorneal tear film.
aDepartment of Ophthalmology, School of Medicine, Baskent University, Ankara, Turkey
bDepartment of Pathology, School of Medicine, Baskent University, Ankara, Turkey
cKeio University School of Medicine, Department of Ophthalmology, Tokyo, Japan.
Inquiries to Dilek Dursun Altinors, MD, 10 Sok, No. 45, 06490, Bahcelievler, Ankara, Turkey
Supported in part by Baskent University, Basic and Clinical Research Fund, and Department of Ophthalmology, Ankara, Turkey.